Type 2 diabetes in general practice in Norway 2005–2014: moderate improvements in risk factor control but still major gaps in complication screening-Reference-Cited by-同舟云学术

Type 2 diabetes in general practice in Norway 2005–2014: moderate improvements in risk factor control but still major gaps in complication screening

Published:2017-11 Issue:1 Volume:5 Page:e000459
ISSN:2052-4897
Container-title:BMJ Open Diabetes Research & Care
language:en
Short-container-title:BMJ Open Diab Res Care

Author:

Bakke Åsne^ORCID,Cooper John G,Thue Geir,Skeie Svein,Carlsen Siri,Dalen Ingvild,Løvaas Karianne Fjeld,Madsen Tone Vonheim,Oord Ellen Renate,Berg Tore Julsrud,Claudi Tor,Tran Anh Thi,Gjelsvik Bjørn,Jenum Anne Karen,Sandberg Sverre

Funder

Merck Sharp and Dohme

Boehringer Ingelheim

Sanofi

Novo Nordisk

Eli Lilly and Company

EkstraStiftelsen Helse og Rehabilitering

Helse Nord RHF

The Endocrinology Research Foundation, Stavanger, Norway

AstraZeneca

University of Oslo, Norway

Norwegian Diabetes Association

Universitetet i Oslo

Helse Nord RHF, Norway

Publisher

BMJ

Subject

Endocrinology, Diabetes and Metabolism

Reference39 articles.

1. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis;Kearney;Lancet,2008

2. Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes;Holman;Lancet,2014

3. Diabetes: Steno-2 - a small study with a big heart;Bajaj;Nat Rev Endocrinol,2016

4. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register;Eeg-Olofsson;Diab Vasc Dis Res,2016

5. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial;Gæde;Diabetologia,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Academic Detailing Compared with Group Meetings to Change Drug Prescribing for Type 2 Diabetes—A Randomized Controlled Trial;Journal of General Internal Medicine;2024-09-04

2. Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus;Frontiers in Clinical Diabetes and Healthcare;2024-05-23

3. Estimates and Predictors of Mortality, Stroke Recurrence, and Functional Dependency 1-Year after Ischemic Stroke: A Prospective Multicenter Longitudinal Cohort Study in Central Norway;Acta Neurologica Scandinavica;2024-05-03

4. Decreasing lifetime prevalence of diabetes-related foot ulcers in Norway: repeated cross-sectional population-based surveys from the HUNT study (1995-2019);Frontiers in Endocrinology;2024-04-17

5. High prevalence of retinopathy in young-onset type 2 diabetes and possible sex differences: insights from Norwegian general practice;BMJ Open Diabetes Research & Care;2024-01